The last 3 authors are equal coauthors.
Elevated hyaluronan and hyaluronan-mediated motility receptor are associated with biochemical failure in patients with intermediate-grade prostate tumors
Version of Record online: 25 MAR 2014
© 2014 American Cancer Society
Volume 120, Issue 12, pages 1800–1809, 15 June 2014
How to Cite
Rizzardi, A. E., Vogel, R. I., Koopmeiners, J. S., Forster, C. L., Marston, L. O., Rosener, N. K., Akentieva, N., Price, M. A., Metzger, G. J., Warlick, C. A., Henriksen, J. C., Turley, E. A., McCarthy, J. B. and Schmechel, S. C. (2014), Elevated hyaluronan and hyaluronan-mediated motility receptor are associated with biochemical failure in patients with intermediate-grade prostate tumors. Cancer, 120: 1800–1809. doi: 10.1002/cncr.28646
The authors thank Dr. Timothy Schacker (supported by NIH grants P01-AI074340, R01-AI093319) for providing computer resources used in this study.
- Issue online: 3 JUN 2014
- Version of Record online: 25 MAR 2014
- Manuscript Accepted: 7 FEB 2014
- Manuscript Revised: 28 JAN 2014
- Manuscript Received: 20 NOV 2013
Additional Supporting Information may be found in the online version of this article.
|cncr28646-sup-0001-suppfig1.tif||1416K||Supplementary Information Figure 1|
|cncr28646-sup-0002-suppfig2.tif||37871K||Supplementary information Figure 2|
|cncr28646-sup-0003-suppfig3.tif||44826K||Supplementary information Figure 3|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.